STN: BLS 125350
Proper Name: Immune Globulin Subcutaneous (Human), 20% Liquid
Tradename: HIZENTRA
Manufacturer: CSL Behring AG
Indication:
Indicated for the treatment of:
- Primary immunodeficiency (PI) in adults and pediatric patients 2 years of age and older.
- Maintenance therapy in adults with indicated for the treatment of: chronic inflammatory demyelinating polyneuropathy (CIDP).
Product Information
Supporting Documents
-
Content current as of:
04/21/2022
